HOME >> BIOLOGY >> NEWS
Recent evolution at a single gene may have brought down heart disease risk in some human groups

Heart disease is Europe's leading cause of death, but new research shows that the disease's toll would be much greater had natural selection not shifted the frequency of susceptibility genes over the past few tens of thousands of years. The work underscores the role of ancient natural selection in shaping contemporary public health.

The findings are reported by Matthew Rockman, Dagan Loisel, and Greg Wray at Duke University, Matthew Hahn at UC Davis, and David Goldstein and Nicole Soranzo at University College London. By analyzing DNA sequences from humans and other primates and comparing sequences among and within human populations, the researchers have cast light on the evolutionary history of a single DNA base pair that has been shown to influence heart disease.

The genetic trait under study concerns a particular base pair of DNA one of billions in the human genome that helps regulate the gene stromelysin-1, or MMP-3. The identity of the DNA base at this position differs between individuals and influences the rate of production of the gene's product, an enzyme that degrades the extracellular matrix that makes up the walls of arteries.

Individuals with the low-expression version of the gene are slightly more prone to atherosclerosis, the narrowing of the arteries associated with the accumulation of plaque in the arterial walls. The new research shows that the high-expression variant increased rapidly in frequency in the ancient European population, though not elsewhere. The rapid increase, which is estimated to have begun around 24,000 years ago, is attributable to the action of natural selection favoring the variant, according to statistical analyses of genetic variation in several human populations.

The researchers' new work also showed that the mutation that created the variant occurred at a site unusually prone to genetic change. By comparing human DNA with that of a diverse range of other primates, they showed that the var
'"/>

Contact: Heidi Hardman
hhardman@cell.com
617-397-2879
Cell Press
6-Sep-2004


Page: 1 2

Related biology news :

1. Recent USGS Work In New England And Beyond
2. Belgian researchers explore revolutionary approach to angiogenesis
3. Pack-MULEs are toting a new look at plant evolution
4. K-State, other universities to study how climate affects plant evolution
5. Genetic analysis rewrites salamanders evolutionary history
6. Heart gene yields insights into evolution, disease risk
7. Broken arms and collateral damage: clues to predator-driven evolution
8. Battle between bubbles might have started evolution
9. Prions act as stepping stones in evolution
10. Study suggests humans can speed evolution
11. Researchers review evolutionary history of modern algae

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... Litmus Health , ... third-party assessment of the company’s security practices has been completed. The assessment deemed ... The comprehensive evaluation reviewed Litmus’ processes and systems, assessing them to see whether ...
(Date:8/26/2020)... ... August 25, 2020 , ... ... pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing ... Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with moderate ...
(Date:8/26/2020)... ... August 25, 2020 , ... Modality Solutions, a biopharmaceutical cold ... Inc. 5000 list. The list is the most prestigious ranking of the nation’s fastest-growing ... for this year’s list, reported three-year revenue growth of 71 percent. , The ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... ... available for free its new white paper – Simulated Transport Methodologies. Regulatory ... today’s biologics licensing application (BLA). In response, Modality Solutions shares an explanation ...
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and ... it did not take off as quickly as people initially expected, and where eSource ... capturing data electronically for clinical trials and then repurposing it for downstream analysis, at ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
Breaking Biology Technology:
Cached News: